Patent Applications published on Jun 25, 2026 - page 3

#601
US20260174591A1
Human necessities

Thermal Contact Pad Assembly

#602
US20260174592A1
Human necessities

Method And Apparatus To Slow Blood Flow Through Extremities During Chemotherapy

#603
US20260174593A1
Human necessities

CONTROLLED EXOTHERMIC HEAT PACK

#604
US20260174594A1
Human necessities

OPHTHALMIC DEVICE

#605
US20260174595A1
Human necessities

SURGICAL TOOL AND METHOD FOR SOFT OCULAR TISSUE TRANSPLANTATION

#606
US20260174596A1
Human necessities

VITREOUS SURGICAL PROBE

#607
US20260174597A1
Human necessities

SYSTEM AND METHOD FOR DISINTEGRATING FLOATERS, INCLUDING NEAR-RETINA FLOATERS, USING ADAPTIVE OPTICS

#608
US20260174598A1
Human necessities

LONG-TERM MONITORING OF THE INCISION PERFORMANCE OF AN OPHTHALMIC LASER SURGICAL SYSTEM

#609
US20260174599A1
Human necessities

PUNCH FOR PARTITIONING A CORNEAL GRAFT AND CORRESPONDING BLADE HOLDER

#610
US20260174600A1
Human necessities

EARPLUG

#611
US20260174601A1
Human necessities

HEARING PROTECTION COMMUNICATION, COMMUNICATION DEVICE WITH WIRELESS AUDIO FUNCTIONALITY CONTROL, AND RELATED METHODS

#612
US20260174602A1
Human necessities

Method for the production of an absorbent structure for sanitary articles and related absorbent structure

#613
US20260174603A1
Human necessities

Folding machines and methods for manufacturing pant products

#614
US20260174604A1
Human necessities

ABSORBENT ARTICLE WITH CHANNELS AND METHOD FOR MANUFACTURING THEREOF

#615
US20260174605A1
Human necessities

BREATHABLE ABSORBENT ARTICLE

#616
US20260174606A1
Human necessities

FLUID MANAGEMENT LAYER FOR AN ABSORBENT ARTICLE

#617
US20260174607A1
Human necessities

Manual Loading Devices And Systems For Use With Patient Transport Apparatuses

#618
US20260174608A1
Human necessities

LEG REST ASSEMBLY FOR A WHEELCHAIR

#619
US20260174609A1
Human necessities

MOBILE MANUAL STANDING WHEELCHAIR

#620
US20260174610A1
Human necessities

ALERT LIGHT METHOD FOR HOSPITAL BED

#621
US20260174611A1
Human necessities

POSTURE ESTIMATION METHOD AND THERMAL MASSAGE MATTRESS USING THE SAME

#622
US20260174612A1
Human necessities

APPARATUS AND SYSTEM FOR BOOSTING, TRANSFERRING, TURNING AND POSITIONING A PATIENT

#623
US20260174613A1
Human necessities

APPARATUS AND SYSTEM FOR BOOSTING, TRANSFERRING, TURNING AND POSITIONING A PATIENT

#624
US20260174614A1
Human necessities

SURGICAL TABLE CLADDING PROTECTION DEVICE

#625
US20260174615A1
Human necessities

Personalized Coffin Cover

#626
US20260174616A1
Human necessities

GAIT TRAJECTORY CONTROL METHOD AND GAIT TRAJECTORY SYSTEM

#627
US20260174617A1
Human necessities

MOBILITY SYSTEMS AND METHODS

#628
US20260174618A1
Human necessities

EYE TREATMENT APPARATUS AND METHOD WITH INDEPENDENT PRESSURE SOURCES

#629
US20260174619A1
Human necessities

BEAUTY APPARATUS

#630
US20260174620A1
Human necessities

SYSTEMS AND METHODS FOR RELEASING MUSCULAR TENSION

#631
US20260174621A1
Human necessities

STIMULATION DEVICE INCLUDING A PRESSURE FIELD GENERATOR AND AIR PASSAGE

#632
US20260174622A1
Human necessities

MASSAGE DEVICE

#633
US20260174623A1
Human necessities

MASSAGE DEVICE

#634
US20260174624A1
Human necessities

INTRAORAL VIBRATION DEVICES AND METHODS FOR INFECTION RESISTANCE

#635
US20260174625A1
Human necessities

INTRAORAL VIBRATION DEVICES AND METHODS FOR AMELIORATING MIDDLE EAR DISORDERS

#636
US20260174626A1
Human necessities

SYSTEMS AND METHODS FOR A HANDHELD NON-VIBRATORY TACTILE-STIMULATION DEVICE WITH INTERCHANGEABLE FILAMENT HEADS

#637
US20260174627A1
Human necessities

APPARATUSES FOR COSMETIC MASSAGE TREATMENT OF THE SKIN

#638
US20260174628A1
Human necessities

VIBRATION THERAPY DEVICE (M.A.V.E.R.I.C.K.), SYSTEM, AND METHOD

#639
US20260174629A1
Human necessities

MASSAGE SPACING ADJUSTING STRUCTURE AND SHOULDER-NECK MASSAGE MACHINE CORE

#640
US20260174630A1
Human necessities

MECHANICAL CPR DEVICE FOR ATTACHMENT TO A FLOOR

#641
US20260174631A1
Human necessities

HOT AND COLD TUB ASSEMBLIES WITH PELTIER TEMPERATURE CONTROLSYSTEMS

#642
US20260174632A1
Human necessities

System and Method for Aseptically Transferring Fluid

#643
US20260174633A1
Human necessities

INJECTION APPARATUS AND METHOD OF USE

#644
US20260174634A1
Human necessities

CONTINUOUS MID-AIR 3-DIMENSIONAL PRINTING FOR PHARMACEUTICAL DOSAGE FORMS

#645
US20260174635A1
Human necessities

DENTAL ADHESIVE COMPOSITION

#646
US20260174636A1
Human necessities

NATURAL DYE COLORING WITH IMPROVED COLOR INTENSITY

#647
US20260174637A1
Human necessities

PERSONAL CARE APPARATUS AND PERSONAL CARE ROOM COMPRISING THE SAME

#648
US20260174638A1
Human necessities

TABLETED, SOLID WATERLESS SINGLE USE COSMETIC COMPOSITION

#649
US20260174639A1
Human necessities

METHOD FOR PREPARING STABLE LIQUID EMULSION FORMS OF PLANT EXTRACT

#650
US20260174640A1
Human necessities

SUNSCREEN FORMULATION COMPRISING MICROCAPSULES, AND PROCESS FOR MANUFACTURING SUCH MICROCAPSULES

#651
US20260174641A1
Human necessities

Oral Care Mousse Compositions And Products Thereof

#652
US20260174642A1
Human necessities

COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING THIS COMPOSITION

#653
US20260174643A1
Human necessities

LIQUID CONTAMINANT ABSORPTION DEVICE AND METHODS OF USE

#654
US20260174644A1
Human necessities

ANTIPERSPIRANT STICK COMPOSITION

#655
US20260174645A1
Human necessities

CROP NUTRITION COMPOSITION

#656
US20260174646A1
Human necessities

Topical detergent composition comprising ascorbyl glucoside and ascorbyl palmitat

#657
US20260174647A1
Human necessities

DEODORANT COMPOSITIONS

#658
US20260174648A1
Human necessities

ZERO-WASTE ECO-FRIENDLY COSMETIC PRODUCT AND METHOD FOR MANUFACTURING SAME

#659
US20260174649A1
Human necessities

OXIDATIVE DYEING AGENT FOR KERATIN FIBERS COMPRISING DYE COUPLER 4-HYDROXYMETHYL-PHENOL; FORMULATIONS THEREOF; AND USES THEREOF

#660
US20260174650A1
Human necessities

OXIDATIVE DYEING AGENT FOR KERATIN FIBERS COMPRISING DYE COUPLER 3,4-DIMETHOXY-BENZOIC ACID; FORMULATIONS THEREOF; AND USES THEREOF

#661
US20260174651A1
Human necessities

Pearlescent Wash Composition

#662
US20260174652A1
Human necessities

A COMPOSITION FOR IMPROVING EFFECTIVENESS OF DYE PRECURSORS FOR CHANGE OF COLOUR OF HAIR

#663
US20260174653A1
Human necessities

COMPOSITIONS FOR IMPARTING COLOR AND TONE TO THE HAIR

#664
US20260174654A1
Human necessities

Methods Of Shifting Biofilm In The Oral Cavity From Pathogenic To Healthy Biofilm

#665
US20260174655A1
Human necessities

SOAP COMPOSITIONS

#666
US20260174656A1
Human necessities

COMPOSITIONS AND METHODS AND USES THERETO

#667
US20260174657A1
Human necessities

COSMETIC CLEANSING CREAM FOR SKIN BRIGHTENING

#668
US20260174658A1
Human necessities

SUNSCREEN COMPOSITION

#669
US20260174659A1
Human necessities

COMPOSITION COMPRISING LARGE AMOUNT OF INORGANIC UV FILTER AND ORGANIC UV FILTER SELECTED FROM ORGANOSILICON COMPOUNDS WITH BENZOTRIAZOLE GROUP

#670
US20260174660A1
Human necessities

UV FILTER COMPOSITION COMPRISING TRITERPENES, EMOLLIENTS AND INORGANIC UV-FILTERS

#671
US20260174661A1
Human necessities

COMPOSITIONS AND METHODS RELATING TO PIGMENTATION

#672
US20260174662A1
Human necessities

COSMETIC COMPOSITION FOR TRICHOLOGICAL ENZYMATIC PEEL FOR THE SCALP AND METHOD OF OBTAINING THEREOF

#673
US20260174663A1
Human necessities

EXTERNAL PREPARATION FOR SKIN

#674
US20260174664A1
Human necessities

COSMETIC CLEANSING PASTE FOR SKIN BRIGHTENING

#675
US20260174665A1
Human necessities

SKIN BRIGHTENING COMPOSITIONS WITH HIGH AMOUNT OF ASCORBIC ACID

#676
US20260174666A1
Human necessities

DRY SHAMPOO WITH INCREASED SOLVENT CONTENT

#677
US20260174667A1
Human necessities

COSMETIC COMPOSITION IN FORM OF A STABLE SUSPENSION

#678
US20260174668A1
Human necessities

IMPROVED INDIGO DYEING METHODS

#679
US20260174669A1
Human necessities

Composition for inhibiting generation of melanin and the use thereof

#680
US20260174670A1
Human necessities

FLAVOR-DEPLETED, FUNCTIONALIZED CITRUS FIBER

#681
US20260174671A1
Human necessities

COMPOSITION FOR ALLEVIATING OR PREVENTING SYMPTOMS OF ALLERGIC RHINITIS OR ALLERGIC CONJUNCTIVITIS

#682
US20260174672A1
Human necessities

COMPLEX FOR IMPROVING SKIN CONDITION

#683
US20260174673A1
Human necessities

COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND TAURINE

#684
US20260174674A1
Human necessities

INCOMPLETE AUTOPHAGY INDUCTION FOR THE TREATMENT OF CANCER

#685
US20260174675A1
Human necessities

INJECTABLE AQUEOUS-BASED LEUCOVORIN FORMULATION AND PREPARATION METHOD THEREOF

#686
US20260174676A1
Human necessities

1,2,4-TRIOXANE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME FOR USE IN THE PREVENTION AND TREATMENT OF CANCER

#687
US20260174677A1
Human necessities

METHODS OF TREATING INSULIN RESISTANCE AND ASSOCIATED DISORDERS

#688
US20260174678A1
Human necessities

OLIGOSACCHARIDES FOR GLYCEMIC CONTROL

#689
US20260174679A1
Human necessities

METHODS OF SELECTING CANCER PATIENTS AMENDABLE TO TREATMENT WITH IMMUNE CHECKPOINT INHIBITOR

#690
US20260174680A1
Human necessities

MAMMARY GLAND TISSUE HEALTH MAINTENANCE AGENT HAVING GABA AS ACTIVE INGREDIENT

#691
US20260174681A1
Human necessities

DRUG FORMULATIONS AND OCULAR IMPLANTS HAVING THE SAME

#692
US20260174682A1
Human necessities

GAMMA-AMINOBUTYRIC ACID DERIVATIVE COMPRISING POLYCYCLIC STRUCTURE, METHOD FOR PREPARING SAME, AND USE THEREOF

#693
US20260174683A1
Human necessities

CHEWABLE COMPOSITION COMPRISING A GUMMY MATRIX AND COMPRISING MELATONIN, SODIUM ALGINATE, AND CALCIUM LACTATE

#694
US20260174684A1
Human necessities

PROBIOTICS FOR USE IN THE TREATMENT OF TUMOR

#695
US20260174685A1
Human necessities

ORAL DISINTEGRATING FILM COMPRISING CANNABINOID AS ACTIVE INGREDIENT AND METHOD OF PREPARING THE SAME

#696
US20260174686A1
Human necessities

USE OF DIGESTION-RESISTANT MALTODEXTRIN AS A PREBIOTIC DIGESTIVE, PROTECTIVE AND STABILIZING MODULATOR ENHANCING THE BIOAVAILABILTY BARRIER

#697
US20260174687A1
Human necessities

PRODUCTS WITH SPHERICAL FILLER

#698
US20260174688A1
Human necessities

POLYAMINE-MODIFIED GELATIN-BASED HYDROGEL AND USE THEREOF

#699
US20260174689A1
Human necessities

READY-TO-USE MORPHINE COMPOSITION AND METHODS

#700
US20260174690A1
Human necessities

METHOD OF ADMINISTERING EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST

#701
US20260174691A1
Human necessities

NANOEMULSION WITHOUT PROPYLENE GLYCOL

#702
US20260174692A1
Human necessities

AEROSOL COMPOSITION

#703
US20260174693A1
Human necessities

MODIFIED PLANT MESSENGER PACKS AND USES THEREOF

#704
US20260174694A1
Human necessities

Lipid Nanoparticle Formulations for Anti-Sense Oligonucleotide Delivery

#705
US20260174695A1
Human necessities

NANOCRYSTAL MICROPARTICLES OF POORLY SOLUBLE DRUGS AND METHODS OF PRODUCTION AND USE THEREOF

#706
US20260174696A1
Human necessities

ORAL PRODUCT

#707
US20260174697A1
Human necessities

METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE AND DERIVATIVES THEREOF, AND TABLETS THEREOF

#708
US20260174698A1
Human necessities

POLYALKYLENE OXIDE PARTICLES, COMPOSITION FOR MEDICINE, COMPOSITION FOR FORMULATION, AND FORMULATION

#709
US20260174699A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING UNIFORM BLENDS OF REBOXETINE

#710
US20260174700A1
Human necessities

A FORMULATION FOR ORAL DELIVERY OF PEPTIDES AND BIOSIMILARS FOR SYSTEMIC ABSORPTION AND METHOD OF MANUFACTURING THE SAME

#711
US20260174701A1
Human necessities

HIGH STRENGTH SINGLE UNIT DOSE FORMULATIONS AND METHODS OF USE THEREOF

#712
US20260174702A1
Human necessities

ANTIDIABETIC ORAL DOSAGE FORMS

#713
US20260174703A1
Human necessities

A GELATIN COMPOSITION AND ITS USE IN THE PRODUCTION OF GELATINE CAPSULES

#714
US20260174704A1
Human necessities

CANCER VACCINES

#715
US20260174705A1
Human necessities

CANCER VACCINES

#716
US20260174706A1
Human necessities

LIPID NANOPARTICLE FORMULATION FOR TRANSPULMONARY DELIVERY OF NUCLEIC ACID DRUGS AND USE THEREOF

#717
US20260174707A1
Human necessities

USE OF GNRH ANTAGONIST IN REGULATION AND CONTROL OF ESTRUS OF MAMMAL

#718
US20260174708A1
Human necessities

MYO-INOSITOL AND THE PREVENTION OF ACCELERATED GROWTH

#719
US20260174709A1
Human necessities

MATRIX TYPE HYROGEL PATCH FOR TOENAIL CARE

#720
US20260174710A1
Human necessities

Compositions and Methods for Treating Arthritis

#721
US20260174711A1
Human necessities

METHODS OF TREATING TRIGEMINAL NERVE PAIN

#722
US20260174712A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RHEUMATOID ARTHRITIS COMPRISING PHENETHYL CINNAMAMIDE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT

#723
US20260174713A1
Human necessities

METHODS FOR TREATING BIOFILMS

#724
US20260174714A1
Human necessities

NONHUMAN ANIMAL AND USE THEREOF

#725
US20260174715A1
Human necessities

FORMULATIONS FOR INJECTABLE COMBINATION PRODUCT CONTAINING ACETAMINOPHEN AND IBUPROFEN

#726
US20260174716A1
Human necessities

CRYSTAL FORM OF ALKYL CARBOXYLIC ACID COMPOUND AND USE THEREOF

#727
US20260174717A1
Human necessities

ULOTARONT FOR TREATING ANXIETY AND ASSOCIATED CONDITIONS

#728
US20260174718A1
Human necessities

MODULATORS OF mTORC1 ACTIVITY AND USES THEREOF

#729
US20260174719A1
Human necessities

BACTEROIDES EGGERTHII KGMB05336 STRAIN AND USE THEREOF

#730
US20260174720A1
Human necessities

NERVONIC ACID COMPOSITION FOR IMPROVING MEMORY-BASED LEARNING FUNCTION AND A PREPARATION METHOD THEREOF

#731
US20260174721A1
Human necessities

AGENT FOR RESTORING METAL HOMEOSTASIS

#732
US20260174722A1
Human necessities

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

#733
US20260174723A1
Human necessities

INJECTABLE PACLITAXEL FORMULATION AND PREPARATION METHOD THEREOF

#734
US20260174724A1
Human necessities

COMPOSITION FOR PREVENTING AND/OR IMPROVING BRAIN DYSFUNCTION

#735
US20260174725A1
Human necessities

SOLID DISPERSION AGENT OF DIMYRICETIN-YL-DISELENIDE AND APPLICATION THEREOF

#736
US20260174726A1
Human necessities

COMPOSITIONS, METHODS, SYSTEMS AND/OR KITS FOR PREVENTING AND/OR TREATING NEOPLASMS

#737
US20260174727A1
Human necessities

APPLICATION OF DI-MYRICETIN DISELENIDE IN DRUG THERAPY FOR TYPE II DIABETES

#738
US20260174728A1
Human necessities

CENTRAL NERVOUS SYSTEM HEALTH SUPPLEMENT

#739
US20260174729A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PLASMODIUM FALCIPARUM MALARIA

#740
US20260174730A1
Human necessities

A COMPOSITION FOR TREATING PARKINSON'S DISEASE

#741
US20260174731A1
Human necessities

ORAL PRODUCT

#742
US20260174732A1
Human necessities

FORMULATIONS AND METHODS RELATED TO EYE IRRITATION

#743
US20260174733A1
Human necessities

PROLIPOSOMAL DELIVERY SYSTEM AND METHOD FOR PREPARING THE SAME

#744
US20260174734A1
Human necessities

PHARMACEUTICAL COMPOSITION

#745
US20260174735A1
Human necessities

STABLE ORAL PHARMACEUTICAL FORMULATIONS

#746
US20260174736A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING AUTISM USING R-ETHOSUXIMIDE

#747
US20260174737A1
Human necessities

COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF PHOTORECEPTOR ROD DEGENERATIONS AND GENERATION OF PHOTORECEPTORS

#748
US20260174738A1
Human necessities

COMPOSITIONS AND METHODS FOR INHIBITING TYPE I COLLAGEN PRODUCTION

#749
US20260174739A1
Human necessities

ARYL-CONTAINING AMINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

#750
US20260174740A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SLOW-FLOW VASCULAR MALFORMATIONS

#751
US20260174741A1
Human necessities

METHODS OF REDUCING MIRO1 OR PHOSPHORYLATED ALPHA-SYNUCLEIN

#752
US20260174742A1
Human necessities

INHIBITORS OF CYCLIC ADP RIBOSE HYDROLASE AND METHODS OF USE THEREOF

#753
US20260174743A1
Human necessities

METHODS FOR STABILIZING LIQUID BACTERIAL ENDOSPORE COMPOSITIONS

#754
US20260174744A1
Human necessities

COMPOUNDS, COMPOSITIONS, AND METHODS OF TREATING RNA VIRAL INFECTIONS

#755
US20260174745A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING NF1 AND OTHER CONDITIONS

#756
US20260174746A1
Human necessities

Pendulum Mounting for Machines for Processing Workpieces of Wood, Plastic, or the Like, and Machine Having at Least One Such Pendulum Mounting

#757
US20260174747A1
Human necessities

COMPUTER IMPLEMENTED METHODS OF GENERATING DOSE RECOMMENDATIONS

#758
US20260174748A1
Human necessities

AGENT FOR ALLEVIATING CLOZAPINE-INDUCED SIALORRHEA

#759
US20260174749A1
Human necessities

COMBINATION THERAPY WITH SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6- DIONE COMPOUNDS

#760
US20260174750A1
Human necessities

PREPARATION OF TRIAZOLOPYRIDINE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS

#761
US20260174751A1
Human necessities

METHOD OF IMPROVING SKELETAL MUSCLE FUNCTION

#762
US20260174752A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

#763
US20260174753A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

#764
US20260174754A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

#765
US20260174755A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

#766
US20260174756A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

#767
US20260174757A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING PULMONARY ARTERIAL HYPERTENSION

#768
US20260174758A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

#769
US20260174759A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

#770
US20260174760A1
Human necessities

FORMULATIONS OF VIMSELTINIB

#771
US20260174761A1
Human necessities

TRANSLOCATOR PROTEIN LIGANDS AND INFLAMMATORY DISEASES

#772
US20260174762A1
Human necessities

OLCEGEPANT FOR TREATING SEPSIS

#773
US20260174763A1
Human necessities

PREPARATION METHOD AND USE OF A NOVEL TAXANE-BASED COMPOUND

#774
US20260174764A1
Human necessities

COMPOSITION AND METHOD FOR REMOVING PLAQUE FROM AN ARTERY

#775
US20260174765A1
Human necessities

Methods for Modulating Complement Factor B Expression

#776
US20260174766A1
Human necessities

COMBINATION OF MENIN INHIBITOR(S) AND IMMUNOPROTEASOME INHIBITOR(S) FOR TREATMENT OF LEUKEMIA

#777
US20260174767A1
Human necessities

PEDIATRIC POWDER FOR ORAL SUSPENSION CONTAINING ANTIVIRAL AGENT AND METHOD FOR THE PREPARATION THEREOF

#778
US20260174768A1
Human necessities

DOSAGE FORMS CONTAINING REBOXETINE HAVING IMPROVED PURITY

#779
US20260174769A1
Human necessities

MACROCYCLIC COMPOUNDS AND METHODS OF USE

#780
US20260174770A1
Human necessities

COMBINATION THERAPY FOR TREATING CANCER

#781
US20260174771A1
Human necessities

NOVEL METHODS FOR CHEMICAL SYNTHESIS OF GLYCOSYLATED SPHINGOSINES

#782
US20260174772A1
Human necessities

METHODS FOR THE TREATMENT OF CANCER USING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA

#783
US20260174773A1
Human necessities

PLATELET COUNT-AGNOSTIC METHODS OF TREATING MYELOFIBROSIS

#784
US20260174774A1
Human necessities

TREATMENTS FOR TOBACCO SMOKE-EXPOSED SUBJECTS INFECTED WITH INFLUENZA VIRUS

#785
US20260174775A1
Human necessities

PROPHYLACTIC AND THERAPEUTIC PHARMACEUTICAL AGENT FOR HIV INFECTIOUS DISEASES CHARACTERIZED BY COMPRISING COMBINATION OF INTEGRASE INHIBITOR AND ANTI-HIV AGENT

#786
US20260174776A1
Human necessities

METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET

#787
US20260174777A1
Human necessities

METHODS OF TREATMENT

#788
US20260174778A1
Human necessities

SULFONAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#789
US20260174779A1
Human necessities

TREATING PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC) WITH IBAT INHIBITORS

#790
US20260174780A1
Human necessities

BISMUTH-THIOL COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES

#791
US20260174781A1
Human necessities

METHODS FOR TREATMENT OF DISEASES

#792
US20260174782A1
Human necessities

USE OF CATIONIC STEROIDAL ANTIMICROBIAL COMPOSITIONS TO TREAT EPIDERMOLYSIS BULLOSA

#793
US20260174783A1
Human necessities

HALOBETASOL PROPIONATE-LIDOCAINE FORMULATIONS

#794
US20260174784A1
Human necessities

Molecular Signatures that Predict Risk for Development of Hepatic Encephalopathy

#795
US20260174785A1
Human necessities

MITOCHONDRIA-TARGETED ATOVAQUONE: A MORE POTENT AND MORE EFFECTIVE ANTITUMOR, ANTIMICROBIAL, AND ANTIMALARIAL DRUG

#796
US20260174786A1
Human necessities

A NITROGEN-CONTAINING SPIROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF

#797
US20260174787A1
Human necessities

HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING GUT MICROBIOME AND METHODS FOR DETERMINING GUT MATURATION STATUS

#798
US20260174788A1
Human necessities

GEMCITABINE FOR USE IN METHODS OF TREATING HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER UNRESPONSIVE TO BACILLUS CALMETTE-GUÉRIN THERAPY

#799
US20260174789A1
Human necessities

N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO

#800
US20260174790A1
Human necessities

HUMAN AND MURINE OPRM1 PROMOTERS AND USES THEREOF

#801
US20260174791A1
Human necessities

MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) TARGETING FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER

#802
US20260174792A1
Human necessities

METHODS FOR TREATMENT OR PREVENTION OF DAMAGE RESULTING FROM RADIATION, TRAUMA OR SHOCK

#803
US20260174793A1
Human necessities

COSMETIC OR PHARMACEUTICAL PREPARATION FOR SKIN CARE AND IMPROVING SKIN CONDITION

#804
US20260174794A1
Human necessities

SELENIUM-CONTAINING HYPERBRANCHED POLYMER (HBP), AND PREPARATION METHOD AND APPLICATION THEREOF

#805
US20260174795A1
Human necessities

SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS

#806
US20260174796A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING BIOFILMS WITHOUT INDUCING ANTIMICROBIAL RESISTANCE

#807
US20260174797A1
Human necessities

MAGNESIUM AND TRACE ELEMENT OXIDE PREMIX FOR ANIMAL NUTRITIONAL SUPPLEMENTATION, AND MANUFACTURING METHOD

#808
US20260174798A1
Human necessities

ANTIBODY AGAINST BLOOD CANCER

#809
US20260174799A1
Human necessities

COMBINATION THERAPY WITH T CELL ENGAGER

#810
US20260174800A1
Human necessities

REGULATION OF CELLS AND ORGANISMS

#811
US20260174801A1
Human necessities

FROZEN ACTIVATED PLATELET COMPOSITIONS AND COLLECTIONS, AND METHODS OF MAKING AND USING THE SAME

#812
US20260174802A1
Human necessities

COMPOSITION FOR PROMOTING DIFFERENTIATION OF STEM CELLS

#813
US20260174803A1
Human necessities

METHODS, COMPOSITIONS, AND KITS FOR IMPROVING PANCREATIC BETA CELL VIABILITY AND TREATING DISEASES OR CONDITIONS RELATED TO BETA CELL DESTRUCTION

#814
US20260174804A1
Human necessities

Amniotic Membrane Method of Use

#815
US20260174805A1
Human necessities

USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS

#816
US20260174806A1
Human necessities

USE OF GUT MICROBIOTA OR METABOLITE THEREOF AND ANTIBODY OR DERIVATIVE THEREOF IN PREPARATION OF DRUG FOR IMMUNOTHERAPY OF COLORECTAL CANCER (CRC)

#817
US20260174807A1
Human necessities

PRODUCT FOR PREVENTING AND/OR TREATING OBESITY AND METABOLIC SYNDROME, METHOD OF PREPARATION AND USE THEREOF

#818
US20260174808A1
Human necessities

COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING COGNITIVE DYSFUNCTION AND ALZHEIMER'S DISEASE COMPRISING LACTOBACILLUS FERMENTUM SRK414 STRAIN

#819
US20260174809A1
Human necessities

MODULATION OF THE GUT MICROBIOME FOR ENHANCEMENT OF GUT AND BRAIN HEALTH

#820
US20260174810A1
Human necessities

METHOD OF FIXATING AND STABILIZING NITRIC OXIDE METABOLITES THROUGH FERMENTATION OF NITROGEN-CONTAINING NATURAL SUBSTANCE

#821
US20260174811A1
Human necessities

METHOD OF FIXATING AND STABILIZING NITRIC OXIDE METABOLITES THROUGH FERMENTATION OF NITROGEN-CONTAINING NATURAL SUBSTANCE

#822
US20260174812A1
Human necessities

DENGUE VACCINE UNIT DOSE AND ADMINISTRATION THEREOF

#823
US20260174813A1
Human necessities

CANCER IMMUNOTHERAPY USING VIRUS PARTICLES AND IMMUNE CHECKPOINT THERAPY

#824
US20260174814A1
Human necessities

COMPOSITION FOR TREATING OR ALLEVIATING MUSCLE LOSS AND MUSCLE ATROPHY CONTAINING OREGONIN COMPOUND DERIVED FROM ALNUS PLANT AS ACTIVE INGREDIENT

#825
US20260174815A1
Human necessities

FEED ADDITIVE FOR IMPROVING HEALTH AND PERFORMANCE OF FARMING ANIMALS

#826
US20260174816A1
Human necessities

NIGELLA SATIVA TREATMENT REGIMEN FOR CARDIAC HYPERTROPHY

#827
US20260174817A1
Human necessities

COMPOSITIONS AND METHODS FOR INHIBITION OF PRECANCER CELLS CONTAINING HPV DNA

#828
US20260174818A1
Human necessities

PEPTIDE ACTIVATING VITAMIN D RECEPTOR, AND COSMETIC COMPOSITION CONTAINING SAME

#829
US20260174819A1
Human necessities

COMPOSITIONS AND METHODS FOR OBTAINING HUMAN ALVEOLAR CELLS AND RELATED USES THEREOF

#830
US20260174820A1
Human necessities

POLYMERS FOR INTRACELLULAR DELIVERY OF POLYNUCLEOTIDES

#831
US20260174821A1
Human necessities

COMPOSITIONS AND METHODS FOR TISSUE REPAIR

#832
US20260174822A1
Human necessities

FUSION PROTEINS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS

#833
US20260174823A1
Human necessities

CGRP/RAMP1 BLOCKADE TO TREAT ENDOMETRIOSIS-ASSOCIATED PAIN AND REDUCE ENDOMETRIOSIS LESIONS

#834
US20260174824A1
Human necessities

ANTIBIOTIC-FREE PLASMID MAINTENANCE SYSTEMS AND METHODS OF USING SAME

#835
US20260174825A1
Human necessities

BIOMIMETIC CHIP, METHOD FOR MANUFACTURING SAME, AND METHOD FOR COATING EXTRACELLULAR MATRIX BY USING SAME

#836
US20260174826A1
Human necessities

HYDROLYZED COLLAGEN COMPOSITIONS AND METHODS OF MAKING THE SAME

#837
US20260174827A1
Human necessities

DRUG CONTAINING ACTIVE SULFUR COMPOUND AS ITS MAIN COMPONENT

#838
US20260174828A1
Human necessities

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DISEASE

#839
US20260174829A1
Human necessities

METHODS OF REDUCING TYPE 2 CYTOKINE-MEDIATED INFLAMMATION USING NEUROMEDIN PEPTIDES

#840
US20260174830A1
Human necessities

OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE

#841
US20260174831A1
Human necessities

METHOD OF TREATMENT OF SOFT TISSUE SARCOMA WITH A PEPTIDE COMPRISING A PCNA INTERACTING MOTIF

#842
US20260174832A1
Human necessities

MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE

#843
US20260174833A1
Human necessities

METHODS OF REDUCING NEUROINFLAMMATION

#844
US20260174834A1
Human necessities

LOW DOSE IL-6 FORMULATIONS AND METHODS OF USE THEREOF

#845
US20260174835A1
Human necessities

ARTICLE OF MANUFACTURE FOR SEMAGLUTIDE COMPOSITIONS

#846
US20260174836A1
Human necessities

COMPOSITION FOR REGULATING PRODUCTION OF PROTEINS

#847
US20260174837A1
Human necessities

COMPOSITIONS COMPRISING NEOANTIGENS AND METHODS OF ENHANCING ANTI-PD1 THERAPY

#848
US20260174838A1
Human necessities

TOLL-LIKE RECEPTOR AGONIST-BASED VACCINE ADJUVANT LIPID COMPOUND AND USE THEREOF

#849
US20260174839A1
Human necessities

PNEUMOCOCCAL AND OTHER VACCINES POTENTIATED WITH SAPONIN ADJUVANT

#850
US20260174840A1
Human necessities

Immunogenic Compositions Containing Non-Natural Amino Acids for the Prevention and Treatment of Pneumococcal Infections

#851
US20260174841A1
Human necessities

METHODS AND COMPOSITIONS OF QUATERNARY IMMUNOMODULATORY NANOPARTICLES FOR MEDICAL APPLICATIONS AND IMMUNOTHERAPY

#852
US20260174842A1
Human necessities

FOOT-AND-MOUTH DISEASE VACCINE

#853
US20260174843A1
Human necessities

Novel Allergen

#854
US20260174844A1
Human necessities

ADMINISTRATION OF VACCINES TO SITES OF TEMPORALLY INDUCED CELL-MEDIATED HYPERSENSITIVITY REACTIONS, TO FACILITATE THE DEVELOPMENT OF PROTECTIVE SENSITIZATION AGAINST INFECTIOUS DISEASES AND CANCERS

#855
US20260174845A1
Human necessities

METHODS OF ENHANCING IMMUNOGENICITY OF POORLY IMMUNOGENIC ANTIGEN-SPECIFIC VACCINES USING ORAL YEAST BETA-GLUCANS

#856
US20260174846A1
Human necessities

ALUMINUM BASED ADJUVANTS FOR TOLEROGENIC VACCINATION

#857
US20260174847A1
Human necessities

METHODS OF TREATING DIGESTIVE DISEASES AND COMPOSITIONS THEREOF

#858
US20260174848A1
Human necessities

METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST

#859
US20260174849A1
Human necessities

T CELL RECEPTOR TARGETING KRAS G12V MUTANT POLYPEPTIDE, AND USE THEREOF

#860
US20260174850A1
Human necessities

ENGINEERED T CELLS HAVING ALTERED PYRUVATE METABOLISM, METHODS FOR THEIR PRODUCTION AND USE IN THERAPY, E.G., FOR TREATMENT OF CANCER OR INFECTION

#861
US20260174851A1
Human necessities

PDE ENHANCED CAR-T CELLS

#862
US20260174852A1
Human necessities

METHODS AND COMPOSITIONS FOR GENERATING IMMUNE CELLS FROM PROGENITOR CELLS

#863
US20260174853A1
Human necessities

CD70-TARGETED CARS AND ENGINEERED CELLS COMPRISING SAME AND RELATED METHODS

#864
US20260174854A1
Human necessities

Systems And Methods For Imaging Diverse Pathogenic Bacteria In Vivo With [18F]Fluoromannitol Positron Emission Tomography

#865
US20260174855A1
Human necessities

DEUTERATED BUPRENORPHINE AS A PROTECTIVE AGENT FOR FETAL SUBJECTS AGAINST FULL-AGONIST OPIOID EXPOSURE

#866
US20260174856A1
Human necessities

USE OF HETEROARYLOXYNAPHTHALENE COMPOUND

#867
US20260174857A1
Human necessities

METHODS OF ADJUVANT TREATMENT FOR ALLERGY IMMUNOTHERAPY

#868
US20260174858A1
Human necessities

TARGETING THE m6A MRNA DEMETHYLASE FTO

#869
US20260174859A1
Human necessities

ISOINDOLINONE DERIVATIVE HAVING ARYLCYCLOALKYLAMIDE STRUCTURE, AND USE THEREOF

#870
US20260174860A1
Human necessities

HYBRID COMPOUNDS OF SCLAREOL AND DOXORUBICIN, THEIR SYNTHESIS AND APPLICATION

#871
US20260174861A1
Human necessities

EXPANSION OF GAMMA DELTA T CELLS, COMPOSITIONS, AND METHODS OF USE THEREOF

#872
US20260174862A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING PRMT5 INHIBITOR AND PD-1/PD-L1 INHIBITOR

#873
US20260174863A1
Human necessities

ISOMERICALLY PURE BETA-CYCLODEXTRIN DERIVATIVES AND USES THEREOF

#874
US20260174864A1
Human necessities

TRANSDERMAL COMPOSITIONS AND METHODS OF PREPARING SAID COMPOSITIONS

#875
US20260174865A1
Human necessities

METHOD FOR OBTAINING BIODEGRADABLE COLLOIDAL PARTICLES

#876
US20260174866A1
Human necessities

METHODS OF TREATING NON-HODGKIN LYMPHOMA

#877
US20260174867A1
Human necessities

REDUCTION OF ADIPOSE TISSUE

#878
US20260174868A1
Human necessities

PREPARATION CONTAINING ANTI-NECTIN-4 ANTIBODY DRUG CONJUGATE AND USE THEREOF

#879
US20260174869A1
Human necessities

PROTEIN POWDER COMPOSITIONS AND METHODS FOR PREPARING THE SAME

#880
US20260174870A1
Human necessities

SYNTHESIS OF BIOMIMETIC CELL WALL STRUCTURE

#881
US20260174871A1
Human necessities

THIXOTROPIC DELIVERY SYSTEMS

#882
US20260174872A1
Human necessities

CYCLODEXTRIN ACID BASE SOLUBILIZATION OF POORLY WATER-SOLUBLE SMALL MOLECULES

#883
US20260174873A1
Human necessities

NUCLEASE-DENDRIMER FORMULATIONS FOR COVID-19 AND BROAD-SPECTRUM ANTIVIRAL THERAPY AND PROPHYLAXIS

#884
US20260174874A1
Human necessities

INSULIN DERIVATIVES

#885
US20260174875A1
Human necessities

TRI-AGONISTS OF THE GLP-1, GIP, AND AMYLIN RECEPTORS

#886
US20260174876A1
Human necessities

CB1 LIGAND CONJUGATED COMPOUNDS AND USES THEREOF

#887
US20260174877A1
Human necessities

COMPOUNDS AND METHODS FOR THE TREATMENT OF DERMAL AND OCULAR DISORDERS

#888
US20260174878A1
Human necessities

IRAK4 DEGRADATION AGENT AND USE THEREOF

#889
US20260174879A1
Human necessities

HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE

#890
US20260174880A1
Human necessities

ELECTROPHILIC REACTIVE LINKERS FOR LABELING OF POLYPEPTIDES AND METHODS OF USE THEREOF

#891
US20260174881A1
Human necessities

Incremental Dose Finding in Controlled-Release PTH Compounds

#892
US20260174882A1
Human necessities

PREPARATION OF LIPID NANOPARTICLE (LNP) CONJUGATES

#893
US20260174883A1
Human necessities

ORAL BIODELIVERY PLATFORM

#894
US20260174884A1
Human necessities

MESSENGER RNA VACCINES AND USES THEREOF

#895
US20260174885A1
Human necessities

POLYPLEXES OF NUCLEIC ACIDS AND TARGETED CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL

#896
US20260174886A1
Human necessities

CONJUGATES COMPRISING A PHOSPHORUS(V) MOIETY AND A PROTAC

#897
US20260174887A1
Human necessities

Antibody, Linkers, Payload, Conjugates and Applications Thereof

#898
US20260174888A1
Human necessities

DUAL PAYLOAD ANTIBODY DRUG CONJUGATES FOR THE TREATMENT

#899
US20260174889A1
Human necessities

STABLE 4-ISOXAZOLINE CONJUGATES

#900
US20260174890A1
Human necessities

CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONOTHIOLATES AND - PHOSPHONATES